Filter
493
Filtered Results: 493
Text search:
V.
Patel
Featured
Recommendations
44
New Publications
66
Language
Document type
No document type
263
Studies & Reports
106
Guidelines
77
Fact sheets
14
Strategic & Response Plan
13
Manuals
12
Training Material
5
Situation Updates
2
Resource Platforms
1
Countries / Regions
India
38
Global
22
Latin America and the Carribbean
15
Russia
12
Brazil
11
Western and Central Europe
11
Eastern Europe
9
South Africa
8
Mozambique
7
Kenya
6
Africa
6
Germany
5
Uganda
4
Nepal
4
Ukraine
4
Angola
4
Nigeria
3
Guinea-Bissau
3
Ethiopia
3
Philippines
3
Syria
3
Indonesia
3
Middle East and North Africa
3
Liberia
2
Ghana
2
Zimbabwe
2
South Sudan
2
Peru
2
Colombia
2
Ecuador
2
Botswana
2
Guatemala
2
Asia
2
Tajikistan
2
Spain
2
Burkina Faso
1
Sierra Leone
1
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Niger
1
Haiti
1
Pakistan
1
Iraq
1
Zambia
1
Egypt
1
Tanzania
1
Thailand
1
Rwanda
1
Bangladesh
1
Malawi
1
Sudan
1
Benin
1
Central African Republic
1
Argentina
1
Dominican Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Cuba
1
Burundi
1
Honduras
1
El Salvador
1
Bolivia
1
Madagascar
1
Mexico
1
Nicaragua
1
Myanmar / Burma
1
Sri Lanka
1
Chile
1
Yemen
1
Eastern Europe and Central Asia
1
Other region
1
Venezuela
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Canada
1
Georgia
1
Belgium
1
France
1
United Kingdom
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
121
Clinical Guidelines
42
Public Health
30
Women & Child Health
16
Key Resources
9
Capacity Building
2
Pharmacy & Technologies
2
Toolboxes
Mental Health
152
COVID-19
75
HIV
45
NCDs
22
Planetary Health
14
Disability
13
TB
13
AMR
13
Health Financing Toolbox
11
NTDs
10
Caregiver
9
Rapid Response
8
Conflict
7
Refugee
7
Natural Hazards
6
Ebola
5
Global Health Education
5
Pharmacy
5
Zika
2
Cholera
1
Polio
1
Specific Hazards
1
Social Ethics
1
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
PLOS One November 20, 2020 https://doi.org/10.1371/journal.pone.0241799 . The first autochthonous case of chikungunya virus (CHIKV) infection in Brazil was in September 2014 in the State of Amapá, and from there it rapidly spread across the country. The present study was conducted in 2016 in the st...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
Este manual se ha elaborado en el marco de la Iniciativa Global de la Organización Mundial de la Salud (OMS) para el Cáncer Infantil, CureAll Americas, con el propósito de mejorar la situación de los niños, niñas y adolescentes con cáncer en todo el mundo, para que puedan tener las mejores po...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnos...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
The majority of Countdown countries did not reach the fourth Millennium Development Goal (MDG 4) on reducing child mortality, despite the fact that donor funding to the health sector has drastically increased. When tracking aid invested in child survival, previous studies have exclusively focused on...
Background: A recent report by the Institute for Health Metrics and Evaluation (IHME) highlights that mental health receives little attention despite being a major cause of disease burden. This paper extends previous assessments of development assistance for mental health (DAMH) in two significant w...
Oral health is defined as the absence of disease and a status that ensures optimal functioning of the mouth and its tissues in a manner preserving the highest level of function and self-esteem. Oral health enables an individual to eat, speak and socialise having no active disease, discomfort or disc...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
Las olas de transmisión de la fiebre amarilla ocurridas en la Región de las Américas entre el 2016 y el 2018 causaron el mayor número de casos humanos y epizoóticos registrados en varios decenios. La fiebre amarilla es una enfermedad hemorrágica viral grave que representa un desafío para el p...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
Little is known about the patterns of development assistance (DA) for each component of reproductive, maternal, newborn, child and adolescent health (RMNCAH) in conflict-affected countries nor about the DA allocation in relation to the burden of disease
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
